September 4-5, 2003
Wyndham Washington Hotel
1400 M Street, NW
Washington, DC 20005
THURSDAY, September 4
1: The Meaning of Federal Funding.
Peter Berkowitz, Associate Professor of Law, George
Mason University Law School; Research Fellow, the Hoover
Institution; and Senior Consultant, the President’s
Council on Bioethics.
2: Stem Cells: The Administration’s Funding Policy:
Legal and Moral Foundations
Discussion of Staff Working Paper, “The Administration’s
Stem Cell Research Funding Policy: Legal and Moral Foundations.”
3: Stem Cells: Moving Research from the Bench
toward the Bedside: The Role of NIH and FDA
Part I (60 min.): Elias A. Zerhouni, M.D., Director,
National Institutes of Health.
Part II (30 min.): Mark B. McClellan, M.D., Commissioner,
Food & Drug Administration.
4: Stem Cells: Moving Research from the Bench toward
the Bedside: The Role of Nongovernmental Activity.
Thomas Okarma, President and CEO, Geron Corporation.
Theo Palmer, Michael J. Fox Foundation for Parkinson’s
William Pursley, President and CEO, Osiris Therapeutics,
Robert Goldstein, Juvenile Diabetes Research Foundation
FRIDAY, September 5